Skip to Main Content

Author Details

Teizo Yoshimura
Center for Cancer Research, National Cancer Institute at Frederick
1981
221
70
PMIDPaper TitleJournal TitlePublished Year
36672419Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators.Cancers (Basel)2023
37322488The beneficial effects of commensal E. coli for colon epithelial cell recovery are related with Formyl peptide receptor 2 (Fpr2) in epithelial cells.Gut Pathog2023
37208442The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.Cell Mol Immunol2023
37003185Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2.Int Immunopharmacol2023
37198402New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.Cell Mol Immunol2023
36902429SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells.Int J Mol Sci2023
35314758Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways.Sci Rep2022
35577819Author Correction: Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways.Sci Rep2022
36096830Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer.Breast Cancer Res2022
33468624Requirement of CRAMP for mouse macrophages to eliminate phagocytosed <i>E. coli</i> through an autophagy pathway.J Cell Sci2021
33538366Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation.FASEB J2021
34856773The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases.Front Biosci (Landmark Ed)2021
35003795Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4<sup>+</sup> and CD8<sup>+</sup> T cells.J Adv Res2021
34818323Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.PLoS One2021
34698088Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer.Curr Issues Mol Biol2021
34390443PolyI:C suppresses TGF-β1-induced Akt phosphorylation and reduces the motility of A549 lung carcinoma cells.Mol Biol Rep2021
33988317Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8[+] T cell infiltrate.J Pathol Clin Res2021
33104252Distinct contributions of cathelin-related antimicrobial peptide (CRAMP) derived from epithelial cells and macrophages to colon mucosal homeostasis.J Pathol2021
32221037A Critical Role of Formyl Peptide Receptors in Host Defense against <i>Escherichia coli</i>.J Immunol2020
32038501The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer.Front Endocrinol (Lausanne)2020
33251986The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer.Technol Cancer Res Treat2020
33219235FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis.Nat Commun2020
32591615Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression.Sci Rep2020
33020583Spred2-deficiency enhances the proliferation of lung epithelial cells and alleviates pulmonary fibrosis induced by bleomycin.Sci Rep2020
32542969Elastin and collagen IV double staining: A refined method to detect blood vessel invasion in breast cancer.Pathol Int2020
30587568Pillars Article: Purification of a Human Monocyte-Derived Neutrophil Chemotactic Factor That Has Peptide Sequence Similarity to Other Host Defense Cytokines. <i>Proc. Natl. Acad. Sci. USA</i> 1987. 84: 9233-9237.J Immunol2019
31888216Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer.Int J Mol Sci2019
31679249The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis.Crit Rev Immunol2019
31446154Negative impact of recipient SPRED2 deficiency on transplanted lung in a mouse model.Transpl Immunol2019
30723473Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.Front Immunol2019
30617600SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.Surg Today2019
29317674Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα.Sci Rep2018
30341215Correction: Deficiency in Fpr2 results in reduced numbers of Lin<sup>-</sup> cKit<sup>+</sup> Sca1<sup>+</sup> myeloid progenitor cells.J Biol Chem2018
30304016Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study.PLoS One2018
29440355The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance.J Immunol2018
29375126Chemokines in homeostasis and diseases.Cell Mol Immunol2018
29375123The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?Cell Mol Immunol2018
28689639Regulation of inflammation by members of the formyl-peptide receptor family.J Autoimmun2017
28413435Low prevalence of human mammary tumor virus (HMTV) in breast cancer patients from Myanmar.Infect Agent Cancer2017
28189389The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments.Cytokine2017
28993690Spred2-deficiecy Protects Mice from Polymicrobial Septic Peritonitis by Enhancing Inflammation and Bacterial Clearance.Sci Rep2017
29151836Corrigendum: Induction of Monocyte Chemoattractant Proteins in Macrophages <i>via</i> the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.Front Immunol2017
28670879Molecular Subtypes of Breast Cancers from Myanmar Women: A Study of 91 Cases at Two Pathology CentersAsian Pac J Cancer Prev2017
26701131New development in studies of formyl-peptide receptors: critical roles in host defense.J Leukoc Biol2016
27904774The G-protein coupled chemoattractant receptor FPR2 promotes malignant phenotype of human colon cancer cells.Am J Cancer Res2016
27869219A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation.Sci Rep2016
26834744Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.Front Immunol2016
26167165Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.Front Immunol2015
26097476Discovery of IL-8/CXCL8 (The Story from Frederick).Front Immunol2015
24432017Non-Myeloid Cells are Major Contributors to Innate Immune Responses via Production of Monocyte Chemoattractant Protein-1/CCL2.Front Immunol2014
  • 1 - 50 of 221

Recommended Authors

Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Career Start Year 2003
Number of shared co-authors 0
University of Amsterdam
Career Start Year 2003
Number of shared co-authors 0
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2002
Number of shared co-authors 0
Medical University of Bialystok
Career Start Year 2001
Number of shared co-authors 0
Trinity College Dublin
Career Start Year 2001
Number of shared co-authors 0
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 0
Center for Perinatal Research, Nationwide Children's Hospital
Career Start Year 1998
Number of shared co-authors 0
Mott Children's Hospital
Career Start Year 1995
Number of shared co-authors 0
Dartmouth Geisel School of Medicine
Career Start Year 1994
Number of shared co-authors 0
West Virginia University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Center for Experimental and Molecular Medicine, University of Amsterdam
Career Start Year 1990
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 6
Atopy Research Center, Juntendo University Graduate School of Medicine
Career Start Year 1989
Number of shared co-authors 0
The Ohio State University, Wexner Medical Center
Career Start Year 1988
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 1987
Number of shared co-authors 0
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
University of Washington
Career Start Year 1986
Number of shared co-authors 0
Crescendo Biologics Ltd
Career Start Year 1986
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
The Ohio State University College of Medicine
Career Start Year 1980
Number of shared co-authors 3
Seattle Children's Research Institute
Career Start Year 1979
Number of shared co-authors 0
Mater Research Institute-UQ, Translational Research Institute
Career Start Year 1977
Number of shared co-authors 0
School of Medicine. University of Connecticut
Career Start Year 1977
Number of shared co-authors 0
University of Florida College of Medicine.
Career Start Year 1977
Number of shared co-authors 0
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1975
Number of shared co-authors 7
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

Co-authored papers 11
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Cancer Research
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
University of California san francisco
Co-authored papers 1
Louisiana State University
Co-authored papers 1
Frederick National Laboratory for Cancer Research
Co-authored papers 1
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Clinical Center, National Institutes of Health
Co-authored papers 1
and Blood Institute
Co-authored papers 1
Co-authored papers 1
School of Public Health, University of Michigan ann arbor
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
University of Virginia
Co-authored papers 1
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
National Cancer Institute-Frederick
Co-authored papers 1
The Scripps Research Institute
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 1
and Blood Institute, National Institutes of Health
Co-authored papers 1
The Second Hospital of Shandong University
Co-authored papers 1
Co-authored papers 1
and Blood Institute
Co-authored papers 1
Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research
Co-authored papers 1